Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health.
The Amarin core values are:
We are honest; We treat everyone with respect; We are accountable for our actions.
We value efficient and effective execution across all levels of the organization with a focus on delivering value to our customers; We appreciate a bias for action.
We work together and support each other’s efforts with the purpose to create value; We are empowered and resourceful and are encouraged to share ideas and learn from one another.
Commitment to quality
We seek to improve patient care through our actions and products; We insist on a culture of quality and continuous improvement; We continuously work at identifying strengths/weaknesses and act swiftly to align with corporate/strategic goals.
Who we are
Meet the Amarin Corporation Executive Team
Here you will find our latest European press releases and media contact details
The European Commission gives green light to a proven new treatment to reduce cardiovascular events such as heart attacks, strokes and cardiac deaths
For general enquires and requests for further information, please email us at[email protected]